Search company, investor...
Vince & Associates Clinical Research company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

About Vince & Associates Clinical Research

Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for more than a decade. The company has become a premier clinical research site by utilizing The Physician Research Model(R) of operation where study teams are led by highly experienced principal investigators intimately involved in all aspects of the clinical trial process.In May 2013, Vince & Associates Clinical Research was acquired by Altasciences. The valuation of Vince & Associates Clinical Research was undisclosed. Other terms of the deal were not released.

Vince & Associates Clinical Research Headquarters Location

10103 Metcalf Avenue

Overland Park, Kansas, 66212,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Vince & Associates Clinical Research News

Syneos Health exec jumps ship to Canadian CRO Altasciences

Aug 8, 2019

Aug 8, 2019 9:30am The Canadian CRO's hire will be focused on helping clients in the earlier stages of devlepoment (Wikimedia Commons) Biopharma and CRO veteran Beatrice Setnik , Ph.D., has become the new chief scientific officer at Canadian clinical research firm Altasciences. Setnik, also a Pfizer alum, joins the company from Syneos Health (created by the merger of inVentiv Health and INC Research) where she spent five years, most recently as its VP of scientific and medical affairs. Altasciences says that as CSO she will go about “supporting our internal and external clients with her expertise in all areas relating to early drug development.” FREE DAILY NEWSLETTER Like this story? Subscribe to FierceBiotech! Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go. “We are extremely fortunate to add a candidate of such caliber and talent to our team. We look forward to Dr. Setnik’s contributions which will reinforce Altasciences’ extensive offerings in early phase preclinical and clinical research,” said Chris Perkin, CEO at Altasciences. Last year, the midsized CRO penned a new deal that saw it snap up the preclinical testing business of SNBL USA. The buyout added “comprehensive preclinical safety testing services” to Altasciences’ current clinical and bioanalytical offerings, according to its PR. Algorithme Pharma, Vince & Associates Clinical Research and Algorithme Pharma USA operate under the Altasciences umbrella. Combined, they boast more than 600 beds for phase I/II studies. Altasciences, which was acquired by Audax Group in June 2017, bought Vince & Associates in 2013. That deal was followed by the launch of Algorithme Pharma USA the next year. Read more on

  • When was Vince & Associates Clinical Research founded?

    Vince & Associates Clinical Research was founded in 2001.

  • Where is Vince & Associates Clinical Research's headquarters?

    Vince & Associates Clinical Research's headquarters is located at 10103 Metcalf Avenue, Overland Park.

  • What is Vince & Associates Clinical Research's latest funding round?

    Vince & Associates Clinical Research's latest funding round is Acquired.

  • Who are the investors of Vince & Associates Clinical Research?

    Investors of Vince & Associates Clinical Research include Altasciences Clinical Research, Gryphon Investors, Celerity Partners and Patriot Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.